BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 30367364)

  • 21. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
    Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
    J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
    [No Abstract]   [Full Text] [Related]  

  • 24. Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer.
    Alwadi D; Felty Q; Yoo C; Roy D; Deoraj A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
    PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
    Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
    Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
    Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
    Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis.
    Gao H; Wang H; Yang W
    Int J Hematol; 2017 Jul; 106(1):99-107. PubMed ID: 28316065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of key candidate genes and miRNA‑mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis.
    Gao C; Zhou C; Zhuang J; Liu L; Wei J; Liu C; Li H; Sun C
    Mol Med Rep; 2019 Jan; 19(1):362-374. PubMed ID: 30431072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
    Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
    Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
    J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer.
    Zhai T; Dou M; Ma Y; Wang H; Liu F; Zhang L; Chong T; Wang Z; Xue L
    Lipids Health Dis; 2023 Mar; 22(1):39. PubMed ID: 36915125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Silico Integration Approach Reveals Key MicroRNAs and Their Target Genes in Follicular Thyroid Carcinoma.
    Hu S; Liao Y; Zheng J; Gou L; Regmi A; Zafar MI; Chen L
    Biomed Res Int; 2019; 2019():2725192. PubMed ID: 31032340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
    Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
    Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of genes and miRNA associated with idiopathic recurrent pregnancy loss: an exploratory data mining study.
    Bahia W; Soltani I; Abidi A; Haddad A; Ferchichi S; Menif S; Almawi WY
    BMC Med Genomics; 2020 Jun; 13(1):75. PubMed ID: 32487076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Wu S; Wu F; Jiang Z
    Oncol Rep; 2017 Oct; 38(4):2043-2050. PubMed ID: 28902367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.